发生CSF3R突变的髓状瘤:超越慢性中性恋白血病
Ahmed Mohamed1, Juehua Gao1, Yi-Hua Chen1
1Department of Pathology, Northwestern University Feinberg School of Medicine, 251 E Huron Street, Chicago, IL, 60611, USA.
Human pathology
|June 15, 2024
概括
CSF3R突变比以前认为的更多的髓状瘤中发现,包括非典型慢性髓状白血病 (aCML) 和急性髓状白血病 (AML). 这些发现表明,CNL可能更好地被归类为骨髓质疏松性/骨髓增殖性瘤.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 激活CSF3R的突变是慢性中性恋白血病 (CNL) 的标志.
- 不同骨髓瘤瘤中CSF3R突变的发生情况并未得到很好的描述.
- 之前的研究表明,CSF3R突变在中枢神经瘤以外的髓状瘤中并不常见.
研究的目的:
- 为了评估CSF3R突变的频谱在各种髓状瘤.
- 为了将CSF3R突变与临床病理特征相关联.
- 调查CSF3R突变骨髓瘤瘤的分子景观和临床结果.
主要方法:
- 对已识别的CSF3R突变的骨髓瘤瘤病例的回顾性分析.
- 对CSF3R的突变查,包括T618I和Q776*变种.
- 对表观遗传修饰剂,结合酶体和瘤抑制剂中同时发生的突变的分析.
- 临床数据审查,包括诊断,治疗和结果.
主要成果:
- 在慢性中性恋白血病 (CNL),非典型慢性髓性白血病 (aCML),急性髓性白血病 (AML),慢性髓性单细胞白血病和骨髓增殖性瘤中发现了CSF3R突变.
- 在50%的病例中存在T618I突变,在25%的病例中存在新的Q776*突变.
- 同时发生的突变经常涉及表观遗传修饰剂和结合细胞;IDH/RUNX1和瘤抑制突变在AML中很常见,但在CNL/aCML中不存在.
- 所有CNL和aCML患者在诊断后两年内死亡.
结论:
- CSF3R突变并不仅限于CNL,并且存在于更广泛的髓状瘤中.
- CNL和aCML具有类似的临床病理学和分子特征.
- 这些发现支持将CNL重新分类为骨髓质疏松性/骨髓扩散性瘤,而不是骨髓扩散性瘤.
更多相关视频
12:05Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
11.6K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
